Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
OnCusp Therapeutics Announces First Patient Dosed in Phase 1 Trial of CUSP06 in Patients with Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors 2024-03-06 21:00
APAX Medical Introduces Cutting-Edge ADVATx Laser For Skin Rejuvenation 2024-03-06 20:22
Latest Updates of Viva Biotech's Portfolio Companies 2024-03-06 19:33
American, Finnish and Canadian governments fund oxygen plant at Tatu City SEZ, Kenya 2024-03-06 18:48
Akeso Announced the First Patient Dosed in Phase III Trial of Cadonilimab(PD-1/CTLA-4) Combined with Chemotherapy versus Tislelizumab Combined with Chemotherapy in First-line Treatment of PD-L1 negative NSCLC 2024-03-06 18:07
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina's Growth Vision 2024-03-06 12:29
AACR 2024 | Ascentage Pharma to Present Three Preclinical Studies at 2024 American Association of Cancer Research Annual Meeting 2024-03-06 08:59
Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024 2024-03-06 08:59
Laminar Pharmaceuticals S.A. receives recommendation from the Independent Data Monitoring Committee to advance to the next stage of CLINGLIO, the phase 2b/3 Clinical Trial of LAM561 in combination with RT and TMZ for adults with newly diagnosed glioblastoma 2024-03-06 08:45
Antengene to Present Four Preclinical Abstracts at AACR 2024, Highlighting Focus on Cancer Immunology, Targeted Agents and Novel Technology Platforms 2024-03-06 08:30
Hummingbird Bioscience to Present Two Posters on Anti-HER3 and Anti-VISTA Antibody Therapeutics at American Association for Cancer Research (AACR) Meeting 2024 2024-03-06 05:30
Datasea Expects Approximately 1,128% Revenue Growth in 2024 2024-03-05 23:45
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free RNase A Production 2024-03-05 22:00
DaVita enters into agreement to expand operations in Brazil and Colombia, enter Chile and Ecuador 2024-03-05 22:00
YS Biopharma Announces Board Changes and Strategic Leadership Appointments in Chinese Subsidiaries 2024-03-05 21:00
WuXi Biologics Achieves Leadership Level in 2023 CDP Climate Change Assessment 2024-03-05 21:00
IRBM Expands Global Reach in Drug Discovery with New Boston Office 2024-03-05 20:24
One Million Global Healthcare Seekers Embrace MedicalTourism.com: Medical Tourism Magazine Leads the Way 2024-03-05 16:00
Innovent and AnHeart Therapeutics Announce the NMPA of China Has Accepted Second NDA for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer 2024-03-05 13:35
First Patient Treated in Phase 2 GvHD Trial 2024-03-05 10:08
1 19 20 21 22 23 892